DEVELOPMENT OF IN VITRO IN VIVO CORRELATION MODELS FOR CLOPIDOGREL TABLETS TO DESCRIBE ADMINISTRATION UNDER FASTING AND FED CONDITIONS

被引:0
|
作者
Savu, Simona Nicoleta [1 ,2 ]
Silvestro, Luigi [2 ]
Mircioiu, Constantin [1 ]
Anuta, Valentina [1 ]
机构
[1] Carol Davila Univ Med & Pharm, Fac Pharm, 6 Traian Vuia St,2nd Dist, Bucharest 020956, Romania
[2] 3S Pharmacol Consultat & Res SRL, 52 Sabinelor St,5th Dist, Bucharest 050853, Romania
关键词
clopidogrel; IVIVC; biorelevant dissolution media; PK profile; fasting; fed; PLATELET REACTIVITY; CLINICAL-EFFICACY; DRUG ABSORPTION; DOSAGE FORMS; GENOTYPE; IMPACT; MEDIA;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The dissolution profiles of clopidogrel 75 mg tablets in compendial gastric and intestinal media as well as in biorelevant simulated gastric and intestinal media mimicking fasting and fed conditions were determined. In vivo plasma concentration curves, that resulted following the administration of the same formulation of clopidogrel to healthy male and female volunteers in fasting and respectively fed state, were used for compartmental modeling of pharmacokinetic data. Data showed that in vivo exposure to clopidogrel increases significantly, when administration of the tablets is performed in fed state. In vitro - in vivo level A linear correlations were established for the intestinal fasting and fed data, using the Loo-Riegleman based deconvolution approach. The developed models confirm that the low solubility of clopidogrel in the biologically relevant absorption site medium is one of the sources of its increased PK variability. The robustness of the IVIVC recommends it as surrogate for in vivo bioavailability testing, being a cheaper and less time consuming initial screening tool for generic formulations.
引用
收藏
页码:302 / 312
页数:11
相关论文
共 50 条
  • [41] Development of an In Vitro Drug Release Method to Enable In Vitro-In Vivo Correlation of Potassium Chloride Extended-Release Tablets
    Qiu, Yihong
    Zhu, Donghua Alan
    Apfelbaum, Kathleen
    Zu, Hui
    Xiong, Hao
    MOLECULAR PHARMACEUTICS, 2022, 19 (11) : 4191 - 4198
  • [42] Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro-in vivo correlation
    Al Durdunji, Amal
    AlKhatib, Hatim S.
    Al-Ghazawi, Mutasim
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 102 : 9 - 18
  • [43] Development of dissolution method for Chuanxinlian tablets based on in vitro-in vivo correlation model for multi-components
    Guo, Pengcheng
    Li, Kun
    Zhao, Jiajia
    Zhang, Meng
    Liu, Kunyao
    Wang, Qizheng
    Zhang, Longlong
    Chen, Sunhui
    Zuo, Zhong
    Wang, Qi
    Wang, Jianxin
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 104
  • [44] APPLICATION OF GASTROINTESTINAL SIMULATION FOR DEVELOPMENT OF IN VITRO-IN VIVO CORRELATION FOR LEVOTHYROXINE SODIUM IMMEDIATE-RELEASE TABLETS
    Kocic, I.
    Homsek, I.
    Dacevic, M.
    Grbic, S.
    Parojcic, J.
    Miljkovic, B.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 44 : 112 - 113
  • [45] Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets
    Karasulu, E
    Aktogu, S
    Karasulu, HY
    Aydogdu, A
    Tuglular, I
    Ertan, G
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2003, 28 (04) : 301 - 307
  • [46] Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets
    E. Karasulu
    S. Aktogu
    H. Y. Karasulu
    A. Aydogdu
    I. Tuglular
    G. Ertan
    European Journal of Drug Metabolism and Pharmacokinetics, 2003, 28 : 301 - 307
  • [47] Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
    Chu, Nannan
    Ding, Ying
    Que, Linling
    Huang, Kai
    Chen, Yuanxing
    Qin, Wei
    Qian, Zhenzhong
    Shi, Yunfei
    Xu, Zhen
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET® XR in healthy volunteers under fasting and fed conditions
    Que, Linling
    Qin, Wei
    Shi, Yunfei
    Ding, Ying
    Huang, Kai
    Qian, Zhenzhong
    Huang, Bingjie
    Zhou, Peipei
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] PHARMACOKINETICS AND TOLERABILITY OF IDP-73152 MESYLATE AFTER A SINGLE ORAL ADMINISTRATION UNDER FASTING AND FED CONDITIONS IN HEALTHY VOLUNTEERS.
    Park, S.
    Shin, D.
    Choi, Y.
    Kang, J.
    Park, S.
    Won, J.
    Jiang, F.
    Lee, H.
    Jiang, I.
    Yu, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S74 - S75
  • [50] UNFOLDING THE METABOLIC PHENOTYPE OF ANGIOPOIETIN-LIKE 3 KNOCK-OUT MOUSE MODELS UNDER FASTING AND FED CONDITIONS
    Terenghi, Ottavia
    Da Dalt, Lorenzo
    Fantini, Francesca
    Moregola, Annalisa
    Bonacina, Fabrizia
    Uboldi, Patrizia
    Norata, Danilo
    ATHEROSCLEROSIS, 2024, 395